Novack Jeffrey Adam sold 200 shares of CareDx, Inc. at $81.05 for −$16.2k on Nov 10, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Secretary and General Counsel
Secretary and General Counsel
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$16,210Shares × reported price
Shares traded
200Common Stock
Price per share
$81.05Reported price. Read footnotes for ranges.
% of reported position traded
0.2%This security and ownership context
Holdings after
97,504Direct
Trade date
Nov 10, 2026Sell
Filed
Nov 12, 2026, 4:29 PM ET2-day reporting delay
Accession
0002019976-26-000016Code S · Transaction 399008
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 97,704 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Sell2,996$80.47−$241,086.32Trade 399007
Nov 10, 2026Sell900$83.33−$74,995.02Trade 399009
3 transaction rows in this filing. Joint filers share the same rows.

CDNA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CDNA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −20%1w ago +11%1d ago +5.8%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on September 4, 2025. F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.05 to $81.04 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.15 to $83.59 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.